Restricted from market entry by regulation, evidence-based procedures and barred from advertising, how should cannabis companies conquer European market entry? Trials are one smart way in the immediate future.
While the USPTO might not register your trademark, there are still some tools available to protect your intellectual property.
Tree of Knowledge, Inc. (CSE: TOKI) has just gone public on the Canadian stock exchange and is aggressively pursuing the European market, including with a 5% acquisition of Macedonian producer NSYK Holdings
Lauren Pahnke makes the case for using CPC to isolate and extract CBD in a pharmaceutical setting.
In shocking news out of Deutschland, BfArM, the federal agency responsible for the management of the first tender cultivation bid, has issued a notice that it is ditching the first tender bid and will start from scratch.
Adelson makes his case for using patient input and more data to spur product innovation.
After several years of wrangling, the British appear to be finally moving forward on legitimizing medical use of cannabis.
The landmark decision to approve a drug derived from cannabis could reflect a major policy shift in the works on a federal level.
Designing a cannabis food product with GMPs, local regulations, ingredient sourcing and scalability in mind can help companies succeed quickly.
Christian Sweeney discusses four key aspects of processing cannabis: cultivation, extraction, analytics and biochemistry.
